IA Trial Radar | ||
|---|---|---|
O estudo clínico NCT07490860 para Carcinoma Pulmonar está ainda não recrutando. Consulte a visualização em cartões do Radar de Estudos Clínicos e as ferramentas de descoberta de IA para ver todos os detalhes. Ou pergunte qualquer coisa aqui. | ||
Um estudo corresponde aos critérios do filtro
Visualização em cartões
A Restorative Justice-Based Lung Cancer Screening Decision-Making Support Intervention Tailored for Black Individuals to Increase Lung Cancer Screening Among Black Community Members, RESTORE Trial 57
Os detalhes do estudo clínico estão disponíveis principalmente em inglês. No entanto, a IA Trial Radar pode ajudar! Basta clicar em 'Explicar o estudo' para visualizar e discutir as informações do estudo no idioma selecionado.
O estudo clínico NCT07490860 é um estudo intervencionista para Carcinoma Pulmonar. Seu status atual é: ainda não recrutando. O recrutamento está programado para iniciar em 1 de julho de 2026, com o objetivo de incluir 57 participantes. Coordenado por Fred Hutchinson Cancer Center e deve ser concluído em 31 de dezembro de 2026. Essas informações foram atualizadas no ClinicalTrials.gov em 24 de março de 2026.
Resumo
This clinical trial develops and studies whether a restorative justice-based lung cancer screening (LCS) decision-making support intervention tailored for Black individuals increases LCS among Black community members. Lung cancer remains the leading cause of cancer deaths among Black men and women. LCS with yearly low-dose chest computed tomography (CT) is recommended for people with current or recent tobacco use (wi...Mostrar mais
Descrição detalhada
OUTLINE: Participants are assigned to 1 of 2 aims.
AIM 1: Participants attend community advisory board (CAB) meetings over 60 minutes on study in support of the co-development and adaptation of the restorative justice-based LCS decision-making support intervention.
AIM 2: Participants attend an in-person restorative justice-based LCS decision-making support session over 2-3 hours on study.
After completion of stud...
Mostrar maisTítulo oficial
Integrating Restorative Practices to Enhance Shared Decision-Making and Uptake of Lung Cancer Screening in Black Community Members (RESTORE)
Condições médicas
Carcinoma PulmonarOutros IDs do estudo
Número NCT
Data de início (real)
2026-07-01
Última atualização postada
2026-03-24
Data de conclusão (estimada)
2026-12-31
Inscrição (estimada)
57
Tipo de estudo
Intervencionista
FASE
N/A
Status
Ainda não recrutando
Propósito principal
Triagem
Alocação do design
Não randomizado
Modelo de intervenção
Grupo único
Cegamento (Mascaramento)
Nenhum (Aberto)
Braços / Intervenções
| Grupo de participantes/Braço | Intervenção/Tratamento |
|---|---|
Nenhuma intervençãoAim 1: Community advisory board (CAB) meetings Participants attend CAB meetings over 60 minutes on study in support of the co-development and adaptation of the restorative justice-based LCS decision-making support intervention. | N/A |
ExperimentalAim 2: Lung cancer screening (LCS) decision-making support session (intervention) Participants attend an in-person restorative justice-based LCS decision-making support session over 2-3 hours on study. | Intervenção educacional Attend LCS decision-making support session Administração de pesquisa Ancillary studies Entrevista Ancillary studies Revisão de prontuário eletrônico de saúde Ancillary studies |
Desfecho primário
Desfecho secundário
| Medida de desfecho | Descrição da medida | Prazo |
|---|---|---|
Intervention acceptability | Assessed using the Acceptability of Intervention Measure (AIM). The AIM will be summarized and presented as a range of scores from 1 (low acceptability/appropriateness) to 5 (high acceptability/appropriateness). | At post-intervention (Day 1) |
Lung cancer screening knowledge | Will be assessed using the Lung Cancer Screening Knowledge 7 question score. Pre- and post-intervention responses will be compared via Chochran-Mantel-Haenszel and Friedman tests. | At pre- and post-intervention (both on Day 1) |
| Medida de desfecho | Descrição da medida | Prazo |
|---|---|---|
Readiness to screen | Will be assessed using the Lung Cancer Screening Health Belief Scales. Participant responses will be summarized with the median and range of scores at pre- and post-intervention. | At pre- and post-intervention (both on Day 1) |
Medical mistrust | Will be assessed using the Discrimination in Medical Setting and Group-Based Medical Mistrust scale. Participant responses will be summarized with the median and range of scores at pre- and post-intervention. | At pre- and post-intervention (both on Day 1) |
Perceived smoking-related stigma | Will be assessed using the Cataldo Lung Cancer Stigma Scale: smoking-related subscale. Participant responses will be summarized with the median and range of scores at pre- and post-intervention. | At pre- and post-intervention (both on Day 1) |
Shared decision-making (SDM) process | Will be assessed using the Shared Decision Making Questionnaire. Participant responses will be summarized with the median and range of scores, with 0 indicating no SDM behavior and 100 indicating ideal SDM behavior. | At post-intervention (Day 1) |
Completion of chest computed tomography (CT) | Will assess completion of chest CT within 90 days post-intervention with no comparison. | Up to 90 days post-intervention |
Intervention acceptability and refinement | Will recruit a subset of participants to participate in a semi-structured interview post-intervention to gain an in-depth understanding of intervention acceptability and intervention refinement, including participant perspectives about the integration of restorative justice-based lung cancer screening decision-making support. Qualitative interview data will be analyzed using a mixed inductive-deductive approach to thematic analysis. | At 90 days post-intervention |
Assistente de participação
Critérios de elegibilidade
Idades elegíveis
Adulto, Idoso
Idade mínima
18 Years
Sexos elegíveis
Todos
Aceita voluntários saudáveis
Sim
- AIM 1: At least 18 years of age
- AIM 1: Individuals who represent LCS-eligible patients, serve as members of Black/African American (AA)-serving community-based organizations (CBOs), and represent key providers, public health, nursing, and medical staff stakeholders
- AIM 2: Identify as Black or African American
- AIM 2: Between ages 50-77
- AIM 2: Self-reported 20-pack year smoking history
- AIM 2: Ongoing commercial tobacco use within the past 15 years
- AIM 2: Proficiency in the English language
- AIM 1: Under 18 years of age
- AIM 1: Non-English speaking community advisory board (CAB) members
- AIM 1: Inability to read written English
- AIM 2: Has a documented chest CT within the past one year
- AIM 2: Personal history of lung cancer or symptoms associated with lung cancer
Fred Hutchinson Cancer Center- AstraZeneca
- Go2 Foundation
Contato central do estudo
Contato: Matthew Triplette, MD, MPH, 206-667-6335, [email protected]
1 Locais do estudo em 1 países
Washington
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, 98109, United States
Matthew Triplette, MD, MPH, Contato, 206-667-6335, [email protected]
Matthew Triplette, MD, MPH, Investigador principal